These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Membrane lymphotoxin is required for resistance to Theiler's virus infection. Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833 [TBL] [Abstract][Full Text] [Related]
8. The tumor necrosis factor ligand and receptor families. Bazzoni F; Beutler B N Engl J Med; 1996 Jun; 334(26):1717-25. PubMed ID: 8637518 [No Abstract] [Full Text] [Related]
9. Tumor necrosis factor receptor superfamily members and their ligands. Armitage RJ Curr Opin Immunol; 1994 Jun; 6(3):407-13. PubMed ID: 7917108 [TBL] [Abstract][Full Text] [Related]
10. [Tumor necrosis factor alpha and beta (TNF-alpha and -beta) in pathogenesis of rheumatoid arthritis]. Yamamura M Nihon Rinsho; 2005 Jan; 63 Suppl 1():145-52. PubMed ID: 15799335 [No Abstract] [Full Text] [Related]
11. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Rennert PD; Browning JL; Hochman PS Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124 [TBL] [Abstract][Full Text] [Related]
12. Endotoxin and the release of tumor necrosis factor receptors. Jansen J; van der Poll T; van Deventer SJ Prog Clin Biol Res; 1994; 388():383-97. PubMed ID: 7831370 [No Abstract] [Full Text] [Related]
13. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin]. Higashi N Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. Hayder H; Blanden RV; Körner H; Riminton DS; Sedgwick JD; Müllbacher A J Immunol; 1999 Aug; 163(3):1516-20. PubMed ID: 10415054 [TBL] [Abstract][Full Text] [Related]
15. The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum. Abe Y; Watanabe Y; Kimura S Surg Today; 1994; 24(3):197-202. PubMed ID: 8003860 [TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types. Aggarwal BB Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060 [No Abstract] [Full Text] [Related]
17. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. Ettinger R; Mebius R; Browning JL; Michie SA; van Tuijl S; Kraal G; van Ewijk W; McDevitt HO Int Immunol; 1998 Jun; 10(6):727-41. PubMed ID: 9678753 [TBL] [Abstract][Full Text] [Related]
18. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function. Alexopoulou L; Pasparakis M; Kollias G J Exp Med; 1998 Aug; 188(4):745-54. PubMed ID: 9705956 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor (TNF) ligand and TNF receptor deficiency affects sleep and the sleep EEG. Deboer T; Fontana A; Tobler I J Neurophysiol; 2002 Aug; 88(2):839-46. PubMed ID: 12163535 [TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]